These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19193420

  • 1. Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction.
    Brock G, Glina S, Moncada I, Watts S, Xu L, Wolka A, Kopernicky V.
    Urology; 2009 Apr; 73(4):756-61. PubMed ID: 19193420
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
    Montorsi F, Verheyden B, Meuleman E, Jünemann KP, Moncada I, Valiquette L, Casabé A, Pacheco C, Denne J, Knight J, Segal S, Watkins VS.
    Eur Urol; 2004 Mar; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM.
    Am J Cardiol; 2006 Jun 15; 97(12):1778-84. PubMed ID: 16765134
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS.
    Eur Urol; 2006 Aug 15; 50(2):351-9. PubMed ID: 16766116
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
    Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, Kopernicky V.
    Asian J Androl; 2006 Nov 15; 8(6):685-92. PubMed ID: 16855765
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
    Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G, Rose L, Lording D, Liang S.
    Diabet Med; 2008 Feb 15; 25(2):138-46. PubMed ID: 18290855
    [Abstract] [Full Text] [Related]

  • 8. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
    Segraves RT, Lee J, Stevenson R, Walker DJ, Wang WC, Dickson RA.
    J Clin Psychopharmacol; 2007 Feb 15; 27(1):62-6. PubMed ID: 17224715
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.
    Saylan M, Khalaf I, Kadioglu A, Shoair KZ, Beheiry A, Wang WC, Kopernicky V, Esen A.
    Int J Clin Pract; 2006 Jul 15; 60(7):812-9. PubMed ID: 16846400
    [Abstract] [Full Text] [Related]

  • 10. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.
    Rajfer J, Aliotta PJ, Steidle CP, Fitch WP, Zhao Y, Yu A.
    Int J Impot Res; 2007 Jul 15; 19(1):95-103. PubMed ID: 16871272
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
    Hellstrom WJ, Gittelman M, Jarow J, Steidle C, McMurray J, Talley D, Watts S, Mitchell CL, McGill JM.
    Eur Urol; 2008 May 15; 53(5):1058-65. PubMed ID: 17945409
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.
    Arch Neurol; 2007 Nov 15; 64(11):1584-92. PubMed ID: 17846260
    [Abstract] [Full Text] [Related]

  • 13. [Observation of safety and efficacy of tadalafil for men with erectile dysfunction].
    Zhu XW, Li FY, Fang JJ.
    Zhonghua Nan Ke Xue; 2006 May 15; 12(5):421-3, 427. PubMed ID: 16755872
    [Abstract] [Full Text] [Related]

  • 14. The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.
    Hazell L, Cornelius V, Wilton LV, Shakir SA.
    BJU Int; 2009 Feb 15; 103(4):506-14. PubMed ID: 18990133
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L, Slagter C, Slob AK, Hop WC.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):439-44. PubMed ID: 16965992
    [Abstract] [Full Text] [Related]

  • 16. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study.
    Fugl-Meyer KS, Stothard D, Belger M, Toll A, Berglund O, Eliasson T, Fugl-Meyer AR.
    Int J Clin Pract; 2006 Nov 01; 60(11):1386-93. PubMed ID: 17073836
    [Abstract] [Full Text] [Related]

  • 17. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study.
    Wespes E, Moncada I, Schmitt H, Jungwirth A, Chan M, Varanese L.
    BJU Int; 2007 Jan 01; 99(1):121-6. PubMed ID: 17227498
    [Abstract] [Full Text] [Related]

  • 18. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L.
    J Urol; 2008 Oct 01; 180(4):1228-34. PubMed ID: 18722631
    [Abstract] [Full Text] [Related]

  • 19. An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.
    Hazell L, Boshier A, Harris S, Wilton LV, Shakir SA.
    BJU Int; 2007 Feb 01; 99(2):387-93. PubMed ID: 17313426
    [Abstract] [Full Text] [Related]

  • 20. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS.
    J Urol; 2007 Apr 01; 177(4):1401-7. PubMed ID: 17382741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.